Incidence and Outcomes of Early Fever Following Haploidentical Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide
Katie S. Gatwood(Vanderbilt University Medical Center), Adetola A. Kassim(Vanderbilt University), Brian G. Engelhardt(Vanderbilt University Medical Center), Bhagirathbhai Dholaria(Vanderbilt University Medical Center), Jacquelyn Day, Kathryn A. Culos(Vanderbilt University Medical Center), Salyka Sengsayadeth(VA Tennessee Valley Healthcare System), Reena Jayani(Vanderbilt University Medical Center), Bipin N. Savani(Vanderbilt University Medical Center), Michael Byrne(Vanderbilt University Medical Center)
Cited by 0
Related Papers
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
|Blood|2016|554
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2016|538
Geriatric Assessment–Driven Intervention (GAIN) on Chemotherapy-Related Toxic Effects in Older Adults With Cancer
|JAMA Oncology|2021|464
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|442
Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation
|Biology of Blood and Marrow Transplantation|2015|409